Social Behavior Tests –Three-Chamber Sociability Test
Analyze social deficits and social recognitions in rodents by implementing the Three-Chamber Sociability Test in your research workflows
Key Research Model Applications of Three-Chamber Sociability Test
The Three-Chamber Sociability Test is used to measure social approach behaviour in mice. After adaptation to the three-chamber arena, a mouse is released into the middle chamber and allowed to explore other compartments. In the adjacent compartments an object or a docile stimulus mouse is situated in a mesh-wire container. The tendency to approach or avoid the compartment with the stimulus mouse provides a measure of sociability.
Mouse Behavioral Testing Made Simple.
Explore our extensive portfolio of validated and tailored behavioral and cognitive rodent tests designed to advance your research.
Three-Chamber Sociability Test Sample Data
The Three-Chamber Sociability Test is used to measure social approach behaviour in mice.
Healthy Control mice have a tendency to socialize, spending more time in the mouse compartment in comparison to the object compartment.
The Three-Chamber Sociability Test is used to measure social approach behaviour in mice.
WT mice spend more time in the compartment that contained a novel stimulus mouse in comparison with the object compartment. In contrast to WT mice, Fmr1 KO do not show a preference for social interaction.
The People Behind Your Research
Thomas Vogels, PhD, In Vivo Neurology Study Director
Leads an expert team of scientists with vast experience in our Neurology models to help you choose the right model and guide your optimal study design. We provide the solution to accelerating your drug development.
Stay Curious: More Articles to Explore
MDX Mouse Model Validation Data
This month we’re highlighting one of the most commonly used mouse models to study Duchenne Muscular Dystrophy (DMD) – the MDX mouse model B10.mdx), and explore how our advanced services can support your efficacy studies in DMD. The X-linked muscular dystrophy (MDX)...
InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research
Researchers will benefit from InnoSer’s preclinical drug development expertise combined with Hasselt University’s foundational knowledge in Multiple Sclerosis (MS) to advance preclinical MS research. Diepenbeek, Belgium, October 16th, 2024 — InnoSer, a leading...
Introduction to InnoSer’s Preclinical Epilepsy Research CRO Platform
Preclinical epilepsy-related research with InnoSer Broadly speaking, epilepsy is a large spectrum of distinct epileptic syndromes that differ in their etiologies, mechanisms, pathophysiological processes, associated comorbidities, and response profile to available...
Phenotyping of a C3-PMP22 mouse model of CMT1A
Charcot-Marie Tooth (CMT) disease is a hereditary, demyelinating peripheral neuropathy, leading to progressive muscle atrophy, weakness and subsequent walking disabilities and sensory impairments. Charcot-Marie Tooth Type 1A (CMT1A) is the most common type of CMT,...
info@innoserlaboratories.com